Abstract:Ghrelin is the only known orexigenic gut hormone, and its synthesis, secretion and degradation are affected by different metabolic statuses. This meta-analysis aimed to investigate the potential differences in plasma acyl ghrelin (AG) and des-acyl ghrelin (DAG) concentrations between normal weight and obese adults. Systematic literature searches of PubMed, Embase and Web of Science through October 2021 were conducted for articles reporting AG or DAG levels in obesity and normal weight, and 34 studies with 1863 participants who met the eligibility criteria were identified. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated to evaluate group differences in circulating AG and DAG levels. Pooled effect size showed significantly lower levels of baseline AG (SMD: − 0.85; 95% CI: − 1.13 to − 0.57; P SMD < 0.001) and DAG (SMD: − 1.06; 95% CI: − 1.43 to − 0.69; P SMD < 0.001) in obese groups compared with healthy controls, and similar results were observed when subgroup analyses were stratified by the assay technique or storage procedure. Postprandial AG levels in obese subjects were significantly lower than those in controls when stratified by different time points (SMD 30 min : − 0.85, 95% CI: − 1.18 to − 0.53, P SMD < 0.001; SMD 60 min : − 1.00, 95% CI: − 1.37 to − 0.63, P SMD < 0.001; SMD 120 min : − 1.21, 95% CI: − 1.59 to − 0.83, P SMD < 0.001). In healthy subjects, a postprandial decline in AG was observed at 120 min (SMD: − 0.42; 95% CI: − 0.77 to − 0.06; P SMD = 0.021) but not in obese subjects (SMD: − 0.28; 95% CI: − 0.60 to 0.03; P SMD = 0.074). The mean change in AG concentration was similar in both the obese and lean health groups at each time point (ΔSMD 30min : 0.31, 95% CI: − 0.35 to 0.97, P SMD = 0.359; ΔSMD 60min : 0.17, 95% CI: − 0.12 to 0.46, P SMD = 0.246; ΔSMD 120min : 0.21, 95% CI: − 0.13 to 0.54, P SMD = 0.224). This meta-analysis strengthens the clinical evidence supporting the following: lower baseline levels of circulating AG and DAG in obese individuals; declines in postprandial circulating AG levels, both for the healthy and obese individuals; a shorter duration of AG suppression in obese subjects after meal intake. These conclusions have significance for follow-up studies to elucidate the role of various ghrelin forms in energy homeostasis.

Circulating PGRN Levels Are Increased but Not Associated with Insulin Sensitivity or Β-Cell Function in Chinese Obese Children.

Factors Associated with Fasting Plasma Ghrelin Levels in Children and Adolescents

Circulating PGRN is significantly associated with systemic insulin sensitivity and autophagic activity in metabolic syndrome.

Circulating progranulin in human infants: relation to prenatal growth and early postnatal nutrition

Circulating Acyl and Des-Acyl Ghrelin Levels in Obese Adults: a Systematic Review and Meta-Analysis

Serum Levels of Progranulin Are Closely Associated with Microvascular Complication in Type 2 Diabetes

PGRN Exerts Inflammatory Effects Via SIRT1-NF-κB in Adipose Insulin Resistance.

Increased Expression of PGRN Protein in Follicular Fluid and Mrna in Granulosa Cells in Overweight Patients with Polycystic Ovary Syndrome.

Serum CTRP3 Levels In Obese Children: A Potential Protective Adipokine Of Obesity, Insulin Sensitivity And Pancreatic β Cell Function.

Expression of progranulin in ovary in high diet induced overweight rats with polycystic ovary syndrome

Plasma ghrelin levels and polymorphisms of ghrelin gene in Chinese obese children and adolescents

Progranulin Induces Adipose Insulin Resistance and Autophagic Imbalance Via TNFR1 in Mice.

The Change in Ghrelin and Obestatin Levels in Obese Children after Weight Reduction

Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity

Changes of Ghrelin Following Oral Glucose Tolerance Test in Obese Children with Insulin Resistance

Level of Plasma Adiponectin and Its Clinical Significance in Children with Obesity

Pgrn Induces Impaired Insulin Sensitivity And Defective Autophagy In Hepatic Insulin Resistance

The growth hormone receptor (GHR) exon 3 polymorphism and its correlation with metabolic profiles in obese Chinese children.

Copeptin and Nesfatin-1 Are Interrelated Biomarkers with Roles in the Pathogenesis of Insulin Resistance in Chinese Children with Obesity

Administration of Progranulin (PGRN) Triggers ER Stress and Impairs Insulin Sensitivity Via PERK-eIF2α-dependent Manner

Copeptin and Nesfatin-1 are interesting interrelated biomarkers playing a role in the pathogenesis of insulin resistance in Chinese obese children